Reduced Incidence of Preterm Delivery with Metronidazole and Erythromycin in Women with Bacterial Vaginosis

Preterm delivery is the primary cause of perinatal mortality in the United States. To date, no effective means of preventing spontaneous preterm delivery has been identified. At least in some cases, however, microbial colonization of the fetal membranes or the amniotic fluid, or alterations in the v...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 1995-12, Vol.333 (26), p.1732-1736
Hauptverfasser: Hauth, John C, Goldenberg, Robert L, Andrews, William W, DuBard, Mary B, Copper, Rachel L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1736
container_issue 26
container_start_page 1732
container_title The New England journal of medicine
container_volume 333
creator Hauth, John C
Goldenberg, Robert L
Andrews, William W
DuBard, Mary B
Copper, Rachel L
description Preterm delivery is the primary cause of perinatal mortality in the United States. To date, no effective means of preventing spontaneous preterm delivery has been identified. At least in some cases, however, microbial colonization of the fetal membranes or the amniotic fluid, or alterations in the vaginal flora such as are seen in patients with bacterial vaginosis, have been associated with spontaneous labor and preterm delivery. 1 – 10 We undertook a prospective, double-blind trial to address three questions. First, does antimicrobial therapy reduce the incidence of preterm delivery in women at risk for preterm delivery? Second, does antimicrobial therapy reduce the . . .
doi_str_mv 10.1056/NEJM199512283332603
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77714928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>9082697</sourcerecordid><originalsourceid>FETCH-LOGICAL-c588t-5b875a953f92c57b89625cd4a2df7cc08a54e4df05764e08f4c61f367cc90e1d3</originalsourceid><addsrcrecordid>eNqFkUuLFDEUhYMoY9v6C0QIIm6G0rxTWerYzoMZFfGxLNLJLSdtVTImVSPtr59IN7MQ0RDI4nz3XHIOQo8peUGJVC_frc4uqDGSMtZyzpki_A5aUMl5IwRRd9GCENY2Qht-Hz0oZUPqocIcoAMtDKVcLdD3j-BnBx6fRhc8RAc49fhDhgnyiN_AEK4hb_HPMF3iC5hyisHbX2kAbKPHq7ydLnMaty5EXO_XNELcwa-tqxbBDviL_RZiKqE8RPd6OxR4tH-X6PPb1aejk-b8_fHp0avzxsm2nRq5brW0RvLeMCf1ujWKSeeFZb7XzpHWSgHC90RqJYC0vXCK9lxVzRCgni_R853vVU4_ZihTN4biYBhshDSXTmtdU6iZ_Q-kmkgma55L9PQPcJPmHOsnOsa4UVpxWSG-g1xOpWTou6scRpu3HSXd78K6vxRWp57sref1CP52Zt9Q1Z_tdVucHfpsa1HlFmNGaElIxQ532DiWLsJm_OfSG4_vqXY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223967635</pqid></control><display><type>article</type><title>Reduced Incidence of Preterm Delivery with Metronidazole and Erythromycin in Women with Bacterial Vaginosis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>New England Journal of Medicine</source><creator>Hauth, John C ; Goldenberg, Robert L ; Andrews, William W ; DuBard, Mary B ; Copper, Rachel L</creator><creatorcontrib>Hauth, John C ; Goldenberg, Robert L ; Andrews, William W ; DuBard, Mary B ; Copper, Rachel L</creatorcontrib><description>Preterm delivery is the primary cause of perinatal mortality in the United States. To date, no effective means of preventing spontaneous preterm delivery has been identified. At least in some cases, however, microbial colonization of the fetal membranes or the amniotic fluid, or alterations in the vaginal flora such as are seen in patients with bacterial vaginosis, have been associated with spontaneous labor and preterm delivery. 1 – 10 We undertook a prospective, double-blind trial to address three questions. First, does antimicrobial therapy reduce the incidence of preterm delivery in women at risk for preterm delivery? Second, does antimicrobial therapy reduce the . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM199512283332603</identifier><identifier>PMID: 7491136</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>Boston, MA: Massachusetts Medical Society</publisher><subject>Adult ; Anti-Bacterial Agents - therapeutic use ; Antitrichomonal Agents - therapeutic use ; Bacterial diseases ; Bacterial diseases of the genital system ; Biological and medical sciences ; Body Weight ; Double-Blind Method ; Erythromycin - therapeutic use ; Female ; Human bacterial diseases ; Humans ; Incidence ; Infections ; Infectious diseases ; Medical sciences ; Metronidazole - therapeutic use ; Obstetric Labor, Premature - epidemiology ; Obstetric Labor, Premature - etiology ; Obstetric Labor, Premature - prevention &amp; control ; Obstetrics ; Pregnancy ; Pregnancy Complications, Infectious - drug therapy ; Premature birth ; Risk Factors ; Treatment Outcome ; Vaginosis, Bacterial - complications ; Vaginosis, Bacterial - drug therapy ; Women</subject><ispartof>The New England journal of medicine, 1995-12, Vol.333 (26), p.1732-1736</ispartof><rights>Copyright © 1995 Massachusetts Medical Society. All rights reserved.</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c588t-5b875a953f92c57b89625cd4a2df7cc08a54e4df05764e08f4c61f367cc90e1d3</citedby><cites>FETCH-LOGICAL-c588t-5b875a953f92c57b89625cd4a2df7cc08a54e4df05764e08f4c61f367cc90e1d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJM199512283332603$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJM199512283332603$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2947500$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7491136$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hauth, John C</creatorcontrib><creatorcontrib>Goldenberg, Robert L</creatorcontrib><creatorcontrib>Andrews, William W</creatorcontrib><creatorcontrib>DuBard, Mary B</creatorcontrib><creatorcontrib>Copper, Rachel L</creatorcontrib><title>Reduced Incidence of Preterm Delivery with Metronidazole and Erythromycin in Women with Bacterial Vaginosis</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Preterm delivery is the primary cause of perinatal mortality in the United States. To date, no effective means of preventing spontaneous preterm delivery has been identified. At least in some cases, however, microbial colonization of the fetal membranes or the amniotic fluid, or alterations in the vaginal flora such as are seen in patients with bacterial vaginosis, have been associated with spontaneous labor and preterm delivery. 1 – 10 We undertook a prospective, double-blind trial to address three questions. First, does antimicrobial therapy reduce the incidence of preterm delivery in women at risk for preterm delivery? Second, does antimicrobial therapy reduce the . . .</description><subject>Adult</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antitrichomonal Agents - therapeutic use</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the genital system</subject><subject>Biological and medical sciences</subject><subject>Body Weight</subject><subject>Double-Blind Method</subject><subject>Erythromycin - therapeutic use</subject><subject>Female</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Metronidazole - therapeutic use</subject><subject>Obstetric Labor, Premature - epidemiology</subject><subject>Obstetric Labor, Premature - etiology</subject><subject>Obstetric Labor, Premature - prevention &amp; control</subject><subject>Obstetrics</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - drug therapy</subject><subject>Premature birth</subject><subject>Risk Factors</subject><subject>Treatment Outcome</subject><subject>Vaginosis, Bacterial - complications</subject><subject>Vaginosis, Bacterial - drug therapy</subject><subject>Women</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkUuLFDEUhYMoY9v6C0QIIm6G0rxTWerYzoMZFfGxLNLJLSdtVTImVSPtr59IN7MQ0RDI4nz3XHIOQo8peUGJVC_frc4uqDGSMtZyzpki_A5aUMl5IwRRd9GCENY2Qht-Hz0oZUPqocIcoAMtDKVcLdD3j-BnBx6fRhc8RAc49fhDhgnyiN_AEK4hb_HPMF3iC5hyisHbX2kAbKPHq7ydLnMaty5EXO_XNELcwa-tqxbBDviL_RZiKqE8RPd6OxR4tH-X6PPb1aejk-b8_fHp0avzxsm2nRq5brW0RvLeMCf1ujWKSeeFZb7XzpHWSgHC90RqJYC0vXCK9lxVzRCgni_R853vVU4_ZihTN4biYBhshDSXTmtdU6iZ_Q-kmkgma55L9PQPcJPmHOsnOsa4UVpxWSG-g1xOpWTou6scRpu3HSXd78K6vxRWp57sref1CP52Zt9Q1Z_tdVucHfpsa1HlFmNGaElIxQ532DiWLsJm_OfSG4_vqXY</recordid><startdate>19951228</startdate><enddate>19951228</enddate><creator>Hauth, John C</creator><creator>Goldenberg, Robert L</creator><creator>Andrews, William W</creator><creator>DuBard, Mary B</creator><creator>Copper, Rachel L</creator><general>Massachusetts Medical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>19951228</creationdate><title>Reduced Incidence of Preterm Delivery with Metronidazole and Erythromycin in Women with Bacterial Vaginosis</title><author>Hauth, John C ; Goldenberg, Robert L ; Andrews, William W ; DuBard, Mary B ; Copper, Rachel L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c588t-5b875a953f92c57b89625cd4a2df7cc08a54e4df05764e08f4c61f367cc90e1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adult</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antitrichomonal Agents - therapeutic use</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the genital system</topic><topic>Biological and medical sciences</topic><topic>Body Weight</topic><topic>Double-Blind Method</topic><topic>Erythromycin - therapeutic use</topic><topic>Female</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Metronidazole - therapeutic use</topic><topic>Obstetric Labor, Premature - epidemiology</topic><topic>Obstetric Labor, Premature - etiology</topic><topic>Obstetric Labor, Premature - prevention &amp; control</topic><topic>Obstetrics</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - drug therapy</topic><topic>Premature birth</topic><topic>Risk Factors</topic><topic>Treatment Outcome</topic><topic>Vaginosis, Bacterial - complications</topic><topic>Vaginosis, Bacterial - drug therapy</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hauth, John C</creatorcontrib><creatorcontrib>Goldenberg, Robert L</creatorcontrib><creatorcontrib>Andrews, William W</creatorcontrib><creatorcontrib>DuBard, Mary B</creatorcontrib><creatorcontrib>Copper, Rachel L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hauth, John C</au><au>Goldenberg, Robert L</au><au>Andrews, William W</au><au>DuBard, Mary B</au><au>Copper, Rachel L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced Incidence of Preterm Delivery with Metronidazole and Erythromycin in Women with Bacterial Vaginosis</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1995-12-28</date><risdate>1995</risdate><volume>333</volume><issue>26</issue><spage>1732</spage><epage>1736</epage><pages>1732-1736</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>Preterm delivery is the primary cause of perinatal mortality in the United States. To date, no effective means of preventing spontaneous preterm delivery has been identified. At least in some cases, however, microbial colonization of the fetal membranes or the amniotic fluid, or alterations in the vaginal flora such as are seen in patients with bacterial vaginosis, have been associated with spontaneous labor and preterm delivery. 1 – 10 We undertook a prospective, double-blind trial to address three questions. First, does antimicrobial therapy reduce the incidence of preterm delivery in women at risk for preterm delivery? Second, does antimicrobial therapy reduce the . . .</abstract><cop>Boston, MA</cop><pub>Massachusetts Medical Society</pub><pmid>7491136</pmid><doi>10.1056/NEJM199512283332603</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 1995-12, Vol.333 (26), p.1732-1736
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_miscellaneous_77714928
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; New England Journal of Medicine
subjects Adult
Anti-Bacterial Agents - therapeutic use
Antitrichomonal Agents - therapeutic use
Bacterial diseases
Bacterial diseases of the genital system
Biological and medical sciences
Body Weight
Double-Blind Method
Erythromycin - therapeutic use
Female
Human bacterial diseases
Humans
Incidence
Infections
Infectious diseases
Medical sciences
Metronidazole - therapeutic use
Obstetric Labor, Premature - epidemiology
Obstetric Labor, Premature - etiology
Obstetric Labor, Premature - prevention & control
Obstetrics
Pregnancy
Pregnancy Complications, Infectious - drug therapy
Premature birth
Risk Factors
Treatment Outcome
Vaginosis, Bacterial - complications
Vaginosis, Bacterial - drug therapy
Women
title Reduced Incidence of Preterm Delivery with Metronidazole and Erythromycin in Women with Bacterial Vaginosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T07%3A53%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20Incidence%20of%20Preterm%20Delivery%20with%20Metronidazole%20and%20Erythromycin%20in%20Women%20with%20Bacterial%20Vaginosis&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Hauth,%20John%20C&rft.date=1995-12-28&rft.volume=333&rft.issue=26&rft.spage=1732&rft.epage=1736&rft.pages=1732-1736&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJM199512283332603&rft_dat=%3Cproquest_cross%3E9082697%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223967635&rft_id=info:pmid/7491136&rfr_iscdi=true